Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
Further Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy CDMO Sector
18-May-2021 -
Charles River Laboratories International, Inc. announced that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene delivery solutions. The purchase ...
acquisitions
cell therapies
Charles River
+1